BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8030974)

  • 1. Inactivation of visna virus and other enveloped viruses by free fatty acids and monoglycerides.
    Thormar H; Isaacs CE; Kim KS; Brown HR
    Ann N Y Acad Sci; 1994 Jun; 724():465-71. PubMed ID: 8030974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides.
    Thormar H; Isaacs CE; Brown HR; Barshatzky MR; Pessolano T
    Antimicrob Agents Chemother; 1987 Jan; 31(1):27-31. PubMed ID: 3032090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virucidal effect of lipids on visna virus, a lentivirus related to HIV.
    Hilmarsson H; Larusson LV; Thormar H
    Arch Virol; 2006 Jun; 151(6):1217-24. PubMed ID: 16388394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of visna virus replication and cytopathic effect in sheep choroid plexus cell cultures by selected anti-HIV agents.
    Thormar H; Balzarini J; Debyser Z; Witvrouw M; Desmyter J; De Clercq E
    Antiviral Res; 1995 May; 27(1-2):49-57. PubMed ID: 7486958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free fatty acids and monoglycerides: anti-infective agents produced during the digestion of milk fat by the newborn.
    Hamosh M
    Adv Exp Med Biol; 1991; 310():151-8. PubMed ID: 1808990
    [No Abstract]   [Full Text] [Related]  

  • 6. Virucidal activities of medium- and long-chain fatty alcohols and lipids against respiratory syncytial virus and parainfluenza virus type 2: comparison at different pH levels.
    Hilmarsson H; Traustason BS; Kristmundsdóttir T; Thormar H
    Arch Virol; 2007; 152(12):2225-36. PubMed ID: 17891329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of milk-derived antimicrobial lipids as antiviral and antibacterial agents.
    Isaacs CE; Thormar H
    Adv Exp Med Biol; 1991; 310():159-65. PubMed ID: 1808991
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and evaluation of microbicidal hydrogels containing monoglyceride as the active ingredient.
    Kristmundsdóttir T; Arnadóttir SG; Bergsson G; Thormar H
    J Pharm Sci; 1999 Oct; 88(10):1011-5. PubMed ID: 10514348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extreme sensitivity of enveloped viruses, including herpes simplex, to long-chain unsaturated monoglycerides and alcohols.
    Sands J; Auperin D; Snipes W
    Antimicrob Agents Chemother; 1979 Jan; 15(1):67-73. PubMed ID: 218499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visna/maedi virus Env protein expressed by a vaccinia virus recombinant induces cell-to-cell fusion in cells of different origins in the apparent absence of Env cleavage: role of glycosylation and of proteoglycans.
    Sánchez AB; Rodríguez D; Garzón A; Amorena B; Esteban M; Rodríguez JR
    Arch Virol; 2002 Dec; 147(12):2377-92. PubMed ID: 12491104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of transgenic sheep that express the visna virus envelope gene.
    Clements JE; Wall RJ; Narayan O; Hauer D; Schoborg R; Sheffer D; Powell A; Carruth LM; Zink MC; Rexroad CE
    Virology; 1994 May; 200(2):370-80. PubMed ID: 8178428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of visna virus infection in lambs with the acyclic nucleoside phosphonate analogue 9-(2-phosphonylmethoxyethyl)adenine (PMEA).
    Thormar H; Georgsson G; Gunnarsson E; Naesens L; Torsteinsdóttir S; Balzarini J; De Clercq E
    Antivir Chem Chemother; 1998 May; 9(3):245-52. PubMed ID: 9875403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maedi-visna virus and its relationship to human immunodeficiency virus.
    Thormar H
    AIDS Rev; 2005; 7(4):233-45. PubMed ID: 16425963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of visna virus envelope neuraminic acid.
    August MJ; Harter DH; Compans RW
    J Virol; 1977 Jun; 22(3):832-4. PubMed ID: 195094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of hepatitis C virus infectivity by human breast milk.
    Pfaender S; Heyden J; Friesland M; Ciesek S; Ejaz A; Steinmann J; Steinmann J; Malarski A; Stoiber H; Tsiavaliaris G; Bader W; Jahreis G; Pietschmann T; Steinmann E
    J Infect Dis; 2013 Dec; 208(12):1943-52. PubMed ID: 24068703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virucidal activities of medium- and long-chain fatty alcohols, fatty acids and monoglycerides against herpes simplex virus types 1 and 2: comparison at different pH levels.
    Hilmarsson H; Kristmundsdóttir T; Thormar H
    APMIS; 2005 Jan; 113(1):58-65. PubMed ID: 15676016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis.
    Vollenbroich D; Ozel M; Vater J; Kamp RM; Pauli G
    Biologicals; 1997 Sep; 25(3):289-97. PubMed ID: 9324997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of visna virus to interferon.
    Carroll D; Ventura P; Haase A; Rinaldo CR; Overall JC; Glasgow LA
    J Infect Dis; 1978 Nov; 138(5):614-7. PubMed ID: 213502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of minimal lesions related to the presence of visna/maedi virus in the mammary gland and milk of dairy sheep.
    Gayo E; Polledo L; Magalde A; Balseiro A; García Iglesias MJ; Pérez Martínez C; Preziuso S; Rossi G; García Marín JF
    BMC Vet Res; 2019 Apr; 15(1):109. PubMed ID: 30967151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of enveloped viruses in human bodily fluids by purified lipids.
    Isaacs CE; Kim KS; Thormar H
    Ann N Y Acad Sci; 1994 Jun; 724():457-64. PubMed ID: 8030973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.